Detalhe da pesquisa
1.
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.
J Intern Med
; 294(3): 295-313, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259686
2.
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Int J Mol Sci
; 24(6)2023 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982875
3.
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
J Pathol Clin Res
; 10(1): e351, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37987115